The Community Guide

- gsearch

Search Results

Narrow Results:

2023 2
2021 1
2020 1
2019 3
2016 2

Journal Article 9

1 - 9 of 9 Results

Refine Results

Refine Results:

Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop

CITE Title : Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop Personal Author(s) : Coffman, Lan G.;Choi, Yun-Jung;McLean, Karen;Allen, Benjamin L.;di Magliano, Marina Pasca;Buckanovich, Ronald J.; Published Date : Feb 9 2016 Source : Oncotarget. 2016; 7(6):6916-6932. URL : https://stacks.cdc.gov/view/cdc/41039 Coffman, Lan G. et al. (2016). Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop. 7(6). Coffman, Lan G. et al. "Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop" 7, no. 6 (2016) Coffman, Lan G. et al. "Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop" vol. 7, no. 6, 2016 Export RIS Citation Information.

:

Coffman, Lan G. ;

Choi, Yun-Jung

Feb 9 2016 | Oncotarget. 2016; 7(6):6916-6932.

:

The tumor microenvironment is critical to cancer growth and therapy resistance. We previously characterized human ovarian carcinoma-associated mesench...
Extracellular Matrix Alterations in Low Grade Lung Adenocarcinoma Compared to Normal Lung Tissue by Imaging Mass Spectrometry

CITE Title : Extracellular Matrix Alterations in Low Grade Lung Adenocarcinoma Compared to Normal Lung Tissue by Imaging Mass Spectrometry Personal Author(s) : Angel, Peggi M.;Bruner, Evelyn;Bethard, Jennifer;Clift, Cassandra L.;Ball, Lauren;Drake, Richard R.;Feghali-Bostwick, Carol; Published Date : 4 2020;4-2020; Source : J Mass Spectrom. 55(4):e4450 URL : https://stacks.cdc.gov/view/cdc/86642 Angel, Peggi M. et al. (2020). Extracellular Matrix Alterations in Low Grade Lung Adenocarcinoma Compared to Normal Lung Tissue by Imaging Mass Spectrometry. 55(4). Angel, Peggi M. et al. "Extracellular Matrix Alterations in Low Grade Lung Adenocarcinoma Compared to Normal Lung Tissue by Imaging Mass Spectrometry" 55, no. 4 (2020) Angel, Peggi M. et al. "Extracellular Matrix Alterations in Low Grade Lung Adenocarcinoma Compared to Normal Lung Tissue by Imaging Mass Spectrometry" vol. 55, no. 4, 2020 Export RIS Citation Information.

:

Angel, Peggi M. ;

Bruner, Evelyn

4 2020 | J Mass Spectrom. 55(4):e4450

:

Lung adenocarcinoma (LUAD) is the second most common cancer, affecting both men and women. Fibrosis is a hallmark of LUAD occurring throughout progres...
Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells

CITE Title : Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells Personal Author(s) : Takenaka, Tomoya;Nakai, Shinya;Katayama, Miku;Hirano, Mami;Ueno, Natsumi;Noguchi, Kosuke;Takatani-Nakase, Tomoka;Fujii, Ikuo;Kobayashi, Susumu S.;Nakase, Ikuhiko; Published Date : October 11 2019 Source : Int J Pharm. 572:118762 URL : https://stacks.cdc.gov/view/cdc/98831 Takenaka, Tomoya et al. (2019). Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells. 572 Takenaka, Tomoya et al. "Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells" 572 (2019) Takenaka, Tomoya et al. "Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells" vol. 572, 2019 Export RIS Citation Information.

:

Takenaka, Tomoya ;

Nakai, Shinya

October 11 2019 | Int J Pharm. 572:118762

:

Extracellular vesicles (exosomes, EVs) are cell membrane particles (30-200 nm) secreted by virtually all cells. During intercellular communication i...
The Microenvironment in Myeloproliferative Neoplasms

CITE Title : The Microenvironment in Myeloproliferative Neoplasms Personal Author(s) : Fleischman, Angela G;Ramanathan, Gajalakshmi; Published Date : 4 2021 Source : Hematol Oncol Clin North Am. 35(2):205-216 URL : https://stacks.cdc.gov/view/cdc/114380 Fleischman, Angela G and Ramanathan, Gajalakshmi (2021). The Microenvironment in Myeloproliferative Neoplasms. 35(2). Fleischman, Angela G and Ramanathan, Gajalakshmi "The Microenvironment in Myeloproliferative Neoplasms" 35, no. 2 (2021) Fleischman, Angela G and Ramanathan, Gajalakshmi "The Microenvironment in Myeloproliferative Neoplasms" vol. 35, no. 2, 2021 Export RIS Citation Information.

:

Fleischman, Angela G ;

Ramanathan, Gajalakshmi

4 2021 | Hematol Oncol Clin North Am. 35(2):205-216

:

Chronic inflammation is a hallmark of myeloproliferative neoplasms (MPNs), with elevated levels of proinflammatory cytokines being commonly found in a...
Induction of cancer-associated fibroblast-like cells by carbon nanotubes dictates its tumorigenicity

CITE Title : Induction of cancer-associated fibroblast-like cells by carbon nanotubes dictates its tumorigenicity Personal Author(s) : Luanpitpong, Sudjit;Wang, Liying;Castranova, Vincent;Dinu, Cerasela Zoica;Issaragrisil, Surapol;Chen, Yi Charlie;Rojanasakul, Yon; Published Date : Dec 20 2016 Source : Sci Rep. 2016; 6. URL : https://stacks.cdc.gov/view/cdc/43680 Luanpitpong, Sudjit et al. (2016). Induction of cancer-associated fibroblast-like cells by carbon nanotubes dictates its tumorigenicity. 6 Luanpitpong, Sudjit et al. "Induction of cancer-associated fibroblast-like cells by carbon nanotubes dictates its tumorigenicity" 6 (2016) Luanpitpong, Sudjit et al. "Induction of cancer-associated fibroblast-like cells by carbon nanotubes dictates its tumorigenicity" vol. 6, 2016 Export RIS Citation Information.

:

Luanpitpong, Sudjit ;

Wang, Liying

Dec 20 2016 | Sci Rep. 2016; 6.

:

Tumor microenvironment has been recognized as a key determinant of tumor formation and metastasis, but how tumor microenvironment is affected by nanom...
Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African-American Women: A Study of PD-L1 and IDO in 112 Cases from the African American Cancer Epidemiology Study (AACES)

CITE Title : Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African-American Women: A Study of PD-L1 and IDO in 112 Cases from the African American Cancer Epidemiology Study (AACES) Personal Author(s) : Mills, Anne M.;Peres, Lauren C.;Meiss, Alice;Ring, Kari L.;Modesitt, Susan C.;Abbott, Sarah E.;Alberg, Anthony J.;Bandera, Elisa V.;Barnholtz-Sloan, Jill;Bondy, Melissa L.;Cote, Michele L.;Funkhouser, Ellen;Moorman, Patricia G.;Peters, Edward S.;Schwartz, Ann G.;Terry, Paul D.;Wallace, Kristin;Schildkraut, Joellen M.; Published Date : Mar 2019 Source : Int J Gynecol Pathol. 38(2):157-170 URL : https://stacks.cdc.gov/view/cdc/58463 Mills, Anne M. et al. (2019). Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African-American Women: A Study of PD-L1 and IDO in 112 Cases from the African American Cancer Epidemiology Study (AACES). 38(2). Mills, Anne M. et al. "Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African-American Women: A Study of PD-L1 and IDO in 112 Cases from the African American Cancer Epidemiology Study (AACES)" 38, no. 2 (2019) Mills, Anne M. et al. "Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African-American Women: A Study of PD-L1 and IDO in 112 Cases from the African American Cancer Epidemiology Study (AACES)" vol. 38, no. 2, 2019 Export RIS Citation Information.

:

Mills, Anne M. ;

Peres, Lauren C.

Mar 2019 | Int J Gynecol Pathol. 38(2):157-170

:

African American women with high-grade serous ovarian carcinoma have worse outcomes compared with women of European descent. Although the discrepancy ...
Non-asbestiform elongate mineral particles and mesothelioma risk: Human and experimental evidence

CITE Title : Non-asbestiform elongate mineral particles and mesothelioma risk: Human and experimental evidence Personal Author(s) : Goodman, Julie E.;Becich, Michael J.;Bernstein, David M.;Case, Bruce W.;Mandel, Jeffrey H.;Nel, Andre E.;Nolan, Robert;Odo, Nnaemeka U.;Smith, Steven R.;Taioli, Emanuela;Gibbs, Graham; Published Date : 8 01 2023;8-01-; Source : Environ Res. 230:114578 URL : https://stacks.cdc.gov/view/cdc/158497 Goodman, Julie E. et al. (2023). Non-asbestiform elongate mineral particles and mesothelioma risk: Human and experimental evidence. 230 Goodman, Julie E. et al. "Non-asbestiform elongate mineral particles and mesothelioma risk: Human and experimental evidence" 230 (2023) Goodman, Julie E. et al. "Non-asbestiform elongate mineral particles and mesothelioma risk: Human and experimental evidence" vol. 230, 2023 Export RIS Citation Information.

:

Goodman, Julie E. ;

Becich, Michael J.

8 01 2023 | Environ Res. 230:114578

:

The presentations in this session of the Monticello II conference were aimed at summarizing what is known about asbestiform and non-asbestiform elonga...
Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival

CITE Title : Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival Personal Author(s) : Qian, Danwen;Liu, Hongliang;Wang, Xiaomeng;Ge, Jie;Luo, Sheng;Patz, Edward F.;Moorman, Patricia G.;Su, Li;Shen, Sipeng;Christiani, David C.;Wei, Qingyi; Published Date : 4 15 2019;4-15-; Source : Int J Cancer. 144(8):1867-1876 URL : https://stacks.cdc.gov/view/cdc/76915 Qian, Danwen et al. (2019). Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival. 144(8). Qian, Danwen et al. "Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival" 144, no. 8 (2019) Qian, Danwen et al. "Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival" vol. 144, no. 8, 2019 Export RIS Citation Information.

:

Qian, Danwen ;

Liu, Hongliang

4 15 2019 | Int J Cancer. 144(8):1867-1876

:

The complement system plays an important role in the innate and adaptive immunity, complement components mediate tumor cytolysis of antibody-based imm...
A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma

CITE Title : A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma Personal Author(s) : Lee, Hyun-Sung;Jang, Hee-Jin;Ramineni, Maheshwari;Wang, Daniel Y.;Ramos, Daniela;Choi, Jong Min;Splawn, Taylor;Espinoza, Monica;Almarez, Michelle;Hosey, Leandria;Jo, Eunji;Hilsenbeck, Susan;Amos, Christopher I.;Ripley, R. Taylor;Burt, Bryan M.; Published Date : 2 01 2023;2-01-; Source : Clin Cancer Res. 29(3):548-559 URL : https://stacks.cdc.gov/view/cdc/149758 Lee, Hyun-Sung et al. (2023). A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma. 29(3). Lee, Hyun-Sung et al. "A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma" 29, no. 3 (2023) Lee, Hyun-Sung et al. "A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma" vol. 29, no. 3, 2023 Export RIS Citation Information.

:

Lee, Hyun-Sung ;

Jang, Hee-Jin

2 01 2023 | Clin Cancer Res. 29(3):548-559

:

Purpose:We report the results of a phase 2, randomized, window-of-opportunity trial of neoadjuvant durvalumab versus durvalumab plus tremelimumab foll...